Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Clinical trial NCT02501902 · COMPLETED

Trial details

NCT number: NCT02501902
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2015-11-23
Primary completion: 2018-10-10
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.